GPT Healthcare announced that the Board of Directors of the Company at its meeting held on 8 November 2025, inter alia, have recommended the interim dividend of Rs 1 per equity Share (i.e. 10%) , subject to the approval of the shareholders.Powered by Capital Market - Live News

Net profit of GPT Healthcare declined 28.48% to Rs 10.60 crore in the quarter ended September 2025 as against Rs 14.82 crore during the previous quarter ended September 2024. Sales rose 12.54% to Rs 118.91 crore in the quarter ended September 2025 as against Rs 105.66 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales118.91105.66 13 OPM %19.1222.17 - PBDT21.9225.49 -14 PBT15.0720.69 -27 NP10.6014.82 -28 Powered by Capital Market - Live News

GPT Healthcare will hold a meeting of the Board of Directors of the Company on 8 November 2025.Powered by Capital Market - Live News

Net profit of GPT Healthcare declined 22.89% to Rs 7.68 crore in the quarter ended June 2025 as against Rs 9.96 crore during the previous quarter ended June 2024. Sales rose 9.50% to Rs 107.11 crore in the quarter ended June 2025 as against Rs 97.82 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales107.1197.82 9 OPM %16.2118.36 - PBDT17.2919.34 -11 PBT11.1114.66 -24 NP7.689.96 -23 Powered by Capital Market - Live News

GPT Healthcare will hold a meeting of the Board of Directors of the Company on 6 August 2025.Powered by Capital Market - Live News